LncRNAs orchestration of gastric cancer - particular emphasis on the etiology, diagnosis, and treatment resistance
Hanan Elimam,Rewan Moussa,Abdullah F. Radwan,Abdulrahman Hatawsh,Nourhan Elfar,Nora A. A. Alhamshry,Mai A. Abd-Elmawla,Nora M. Aborehab,Mohamed Bakr Zaki,Sherif S. Abdel Mageed,Osama A. Mohammed,Mustafa Ahmed Abdel-Reheim,Ahmed S. Doghish
DOI: https://doi.org/10.1007/s10142-024-01450-8
2024-09-27
Functional & Integrative Genomics
Abstract:Gastric cancer (GC) remains a major public health challenge worldwide. Long non-coding RNAs (lncRNAs) play important roles in the development, progression, and resistance to the treatment of GC, as shown by recent developments in molecular characterization. Still, an in-depth investigation of the lncRNA landscape in GC is absent. However, The objective of this systematic review is to evaluate our present understanding of the role that lncRNA dysregulation plays in the etiology of GC and treatment resistance, with a focus on the underlying mechanisms and clinical implications. Research that described the functions of lncRNA in angiogenesis, stemness, epigenetics, metastasis, apoptosis, development, and resistance to key treatments was given priority. In GC, it has been discovered that a large number of lncRNAs, including MALAT1, HOTAIR, H19, and ANRIL, are aberrantly expressed and are connected with disease-related outcomes. Through various methods such as chromatin remodeling, signal transduction pathways, and microRNA sponging, they modulate hallmark cancer capabilities. Through the activation of stemness programs, epithelial-mesenchymal transition (EMT), and survival signaling, LncRNAs also control resistance to immunotherapy, chemotherapy, and targeted therapies. By clarifying their molecular roles further, we may be able to identify new treatment targets and ways to overcome resistance. This article aims to explore the interplay between lncRNAs, and GC. Specifically, the focus is on understanding how lncRNAs contribute to the etiology of GC and influence treatment resistance in patients with this disease.
genetics & heredity